Key result
Higher spot-ACR is linked to ~41% higher CVD event risk per ln-SD.
Cohort (n=2,627)
Answers are grounded in this paper and cite their sources.
BACKGROUND AND OBJECTIVES: In the albumin-to-creatinine ratio (spot-ACR), urine creatinine corrects for tonicity but also reflects muscle mass. Low muscle mass is associated with cardiovascular disease (CVD). We hypothesized that the spot-ACR would be higher in women, lower-weight persons, and older individuals, independent of timed urine albumin excretion (24hr-UAE), and accordingly, that spot-ACR would be more strongly associated with CVD events than 24hr-UAE in these subgroups. DESIGN, SETTING, PARTICIPANTS, & METHODS: 2627 PREVEND (Prevention of Renal and Vascular End-stage Disease) participants with 24hr-UAE <30 mg/d were followed for CVD events for 11 years. Cox regression evaluated associations of spot-ACR and 24hr-UAE with CVD events by sex, weight, and age. RESULTS: Female sex (26%), lower weight (2% per 5 kg), and older age (4% per 5 years) were associated with higher spot-ACR independent of 24hr-UAE (P<0.001). Spot urine albumin concentration (hazard ratio [HR], 1.26 per ln-SD higher) and 1/spot urine creatinine concentration (HR, 1.16 per ln-SD higher) were associated with CVD events. Spot-ACR was more strongly associated with CVD events than either component of the ratio (HR, 1.41 per ln-SD higher). Associations of spot-ACR ≥10 mg/g versus less (HR, 2.33) and 24hr-UAE ≥10 mg/d versus less (HR, 2.09) with CVD events were similar, and there were no significant differences across subgroups (P for interactions >0.06). CONCLUSIONS: In community-living individuals with 24hr-UAE <30 mg/d, spot-ACR is higher in women, older persons, and lower-weight persons, independent of 24hr-UAE. Low spot urine creatinine is associated with CVD risk, but high urine albumin is a stronger determinant of the association of spot-ACR with CVD than is low urine creatinine.
No takes yet. Share an insight, caveat, or question.
Carter et al. (2012) conducted a cohort in Cardiovascular disease risk in individuals with normal timed urine albumin excretion (n=2,627). Spot urine albumin-to-creatinine ratio (spot-ACR) vs. 24-hour timed urine albumin excretion (24hr-UAE) and individual urine albumin/creatinine components was evaluated on Cardiovascular disease (CVD) events (HR 1.41 per ln-SD higher). Spot-ACR predicted CVD events more strongly than spot urine albumin or creatinine alone, while spot-ACR ≥/g and 24hr-UAE ≥/d showed similar risk.
Synapse has enriched 10 related papers. Consider them for comparative context: